معرفی
Saara Marttila is a Senior Research Fellow in Biomedicine, actively contributing to research in epigenetics, particularly DNA methylation and epigenetic aging. Her work is closely associated with population-based studies such as the Young Finns Study, and she has published extensively on topics including VTRNA2-1 (nc886), immune cell composition, and circulatory miRNAs. She collaborates with national and international researchers and has a strong publication record in high-impact journals.
Her research interests center on epigenetic mechanisms of aging, with a focus on DNA methylation patterns across tissues, populations, and developmental stages. She investigates how lifestyle factors such as sleep, shift work, and metabolic health influence biological aging. Her work bridges molecular biology and public health, aiming to identify biomarkers for disease risk and aging trajectories.
The recent articles highlight a strong trend toward understanding biological aging through epigenetic lenses, particularly in blood cell types and under environmental stressors. Her publications span cardiovascular disease, oncology, sleep medicine, and immunology, demonstrating interdisciplinary impact. Keywords across her work include DNA methylation, epigenetic clocks, nc886, VTRNA2-1, and population genomics.
Scientific contributions and collaborations include:
- Co-authorship on major epigenetic studies in cohort populations
- Development and analysis of epigenetic datasets related to aging and methylation
- Active participation in conference presentations, such as on chromatin binding mechanisms
- Contributions to meta-analyses and longitudinal epigenetic research
Saara Marttila has been involved in advising and collaborative research, though specific students are not listed. She has contributed to significant grants and projects, particularly those related to the Young Finns Study and epigenetic biomarker discovery. Her work is supported by data sharing through repositories like figshare, indicating strong research infrastructure involvement.
She is part of a broader research network focused on epigenetic aging, methylation dynamics, and biomedical applications of epigenomic data. Her team includes collaborators from Finland and abroad, working on topics ranging from cancer epigenetics to cardiovascular health. Future work is likely to expand on cell-type-specific aging and the role of non-coding RNAs in disease.
